Value-based care group Revo Health said last week it inked a strategic partnership with Medtronic (NYSE:MDT) to develop patient-payment models aiming to enhance patient outcomes and reduce costs.
As part of the agreement, Fridley, Minn.-based Medtronic made a minority investment in Revo Health, the company said in a press release.
Revo Health, which was founded last July and organized by Twin Cities Orthopedics, offers episode-of-care bundle development, quality improvement, general business-process outsourcing and ambulatory surgery center solutions, according to a press release.
Last month, Medtronic, in partnership with IBM Watson Health, announced the commercial availability of its AI-powered Sugar.IQ diabetes management app.